Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qudsia Arif

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Archives of Pathology & Laboratory Medicine|August 1, 2015
Malignant Mesothelioma DiagnosisQudsia Arif, Aliya N Husain
Archives of Pathology & Laboratory Medicine|August 1, 2009
Update in nonneoplastic lung diseasesIlyssa O Gordon, Nicole Cipriani, Qudsia Arif, et al.
Cancer Research|December 6, 2013
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancerIchiro Kawada, Rifat Hasina, Qudsia Arif, et al.
The Annals of Thoracic Surgery|October 22, 2016
Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural MesotheliomaWickii T Vigneswaran, Diana Y Kircheva, Vijayalakshimi Ananthanarayanan, et al.
Plos One|September 16, 2014
MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesotheliomaRajani Kanteti, Immanuel Dhanasingh, Ichiro Kawada, et al.
Journal of Carcinogenesis|December 10, 2013
O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancerRifat Hasina, Mosmi Surati, Ichiro Kawada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2025
Deep Learning Discriminates Thymic Epithelial Tumors Histological Subtypes Using Digital PathologyMatteo Sacco, Erica Pietroluongo, Anna Di Lello, et al.
Scientific Reports|April 16, 2016
Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesotheliomaFrances E Lennon, Gianguido C Cianci, Rajani Kanteti, et al.
Molecular Cancer Therapeutics|December 12, 2013
Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancerCleo E Rolle, Rajani Kanteti, Mosmi Surati, et al.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Archives of Pathology & Laboratory Medicine|August 1, 2015
Malignant Mesothelioma DiagnosisQudsia Arif, Aliya N Husain
Archives of Pathology & Laboratory Medicine|August 1, 2009
Update in nonneoplastic lung diseasesIlyssa O Gordon, Nicole Cipriani, Qudsia Arif, et al.
Cancer Research|December 6, 2013
Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancerIchiro Kawada, Rifat Hasina, Qudsia Arif, et al.
The Annals of Thoracic Surgery|October 22, 2016
Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural MesotheliomaWickii T Vigneswaran, Diana Y Kircheva, Vijayalakshimi Ananthanarayanan, et al.
Plos One|September 16, 2014
MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesotheliomaRajani Kanteti, Immanuel Dhanasingh, Ichiro Kawada, et al.
Journal of Carcinogenesis|December 10, 2013
O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancerRifat Hasina, Mosmi Surati, Ichiro Kawada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2025
Deep Learning Discriminates Thymic Epithelial Tumors Histological Subtypes Using Digital PathologyMatteo Sacco, Erica Pietroluongo, Anna Di Lello, et al.
Scientific Reports|April 16, 2016
Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesotheliomaFrances E Lennon, Gianguido C Cianci, Rajani Kanteti, et al.
Molecular Cancer Therapeutics|December 12, 2013
Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancerCleo E Rolle, Rajani Kanteti, Mosmi Surati, et al.
Oncogenesis|September 6, 2019
EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesotheliomaYi-Hung Carol Tan, Saumya Srivastava, Brian M Won, et al.
Pageof 2